e-learning
resources
Barcelona 2013
Monday, 09.09.2013
COPD mechanisms
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The prevalence of COPD in patients participated in rehabilitation program after myocardial infarction
B. Milenkovic, M. Andjic, I. Zivkovic, D. Bulatovic, M. Lazovic, T. Cvok, J. Jankovic (Belgrade, Republic Of Serbia)
Source:
Annual Congress 2013 –COPD mechanisms
Session:
COPD mechanisms
Session type:
Thematic Poster Session
Number:
2139
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Milenkovic, M. Andjic, I. Zivkovic, D. Bulatovic, M. Lazovic, T. Cvok, J. Jankovic (Belgrade, Republic Of Serbia). The prevalence of COPD in patients participated in rehabilitation program after myocardial infarction. Eur Respir J 2013; 42: Suppl. 57, 2139
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19
Related content which might interest you:
One year experience with acute COPD assessment service (ACAS) for patients with acute exacerbations of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 178s
Year: 2006
Beta-blocker use and risk of acute exacerbations of COPD following first-time myocardial infarction. A Danish nationwide cohort study.
Source: International Congress 2019 – More and more COPD
Year: 2019
COPD as undetected cause of dyspnea in patients admitted with ischaemic heart disease (IHD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Comorbit coronary artery disease is related to worse outcomes in patients hospitalised for COPD exacerbation
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Gender differences in hospitalized patients with acute exacerbation of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Results of an exercise intervention in frail older patients with acute exacerbation of COPD
Source: International Congress 2016 – Physiotherapy interventions and assessment options in hospitalised patients
Year: 2016
Predictors of coronary heart disease in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Effect of basic therapy of chronic obstructive pulmonary disease on the clinical course of acute myocardial infarction
Source: International Congress 2014 – Comorbidities
Year: 2014
Acute myocardial infarction among Spanish adults with and without COPD: Cumulative incidence and outcomes
Source: International Congress 2014 – COPD markers
Year: 2014
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Myocardial infarction, heart failure and mortality in patients with COPD in primary care.
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Impact of co-morbidities on the rehabilitation outcome in COPD patients
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007
Underlying ischaemic heart disease assessed by cardiac infarction injury score (CIIS) is under-recognised in our patients hospitalised for COPD exacerbation
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Prevalence and underdiagnosis of COPD in patients with ischemic heart disease demonstrated by coronary angiography. Prognostic implications
Source: International Congress 2015 – COPD: notable points
Year: 2015
The outcome of patients with COPD admitted to UK hospitals with an exacerbation. Results from the RCP/BTS national COPD audit
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
Characteristics of frail patients with acute exacerbations of COPD who experience readmissions.
Source: International Congress 2019 – A fresh view on assessment of functional status in COPD
Year: 2019
Risk of myocardial infarction (MI) associated with acute exacerbations of COPD (AECOPD): Effects of exacerbation frequency
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016
Co-morbidity and hospitalization rate in patients (pts) with acute exacerbation (AE) of COPD
Source: International Congress 2015 – Different data in COPD
Year: 2015
Cognitive dysfunction is greater in patients hospitalised with COPD exacerbations than with worsening heart failure
Source: International Congress 2014 – Markers
Year: 2014
Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. A comparative syudy
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept